ArticleFrontiers in veterinary science2025
Seroprevalence and risk factors for sheep pox and goat pox among small ruminant herds from Nakapiripirit and Sembabule districts, Uganda.
Article in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sheep and goat pox: vaccines and vaccination scenarios to control the epidemics in Greece and Bulgaria in 2025.EFSA journal. European Food Safety Authority · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sheep pox and goat pox diseases[SP&GP] caused by sheep poxvirus and goat poxvirus, respectively are transboundary, World Organization for Animal Health class A-notifiable viral diseases. In Uganda, despite the inevitable national underreporting, suspected sheep pox and goat pox outbreaks have been reported from passive surveillance. There are limited sheep pox and goat pox serological data in small ruminants in Uganda. Materials and methods: A cross-sectional study was conducted in Sembabule and Nakapiripirit Districts, largely representing semi-intensive and communal/pastoral small ruminant production systems, respectively, between May and September 2023 to (i) determine the seroprevalence of sheep pox and goat pox virus antibodies in goats and sheep and (ii) identify the risk factors for the spread and transmission of SP&GP in small ruminant herds. A total of 1,515 serum samples were collected from 63 farms/clusters in Sembabule [ Results: Of the total samples tested, [ Conclusion: This study confirmed exposure to SP&GPV in goats and sheep to varying degrees in the districts studied. We recommend, based on evidence, an extended nationwide evaluation of antibody seroprevalence in goats and sheep to inform national-level SP&GP control efforts. To the best of our knowledge, this is the first documented systematic study to evaluate the seroprevalence of S&GPV antibodies in sheep and goats in the two districts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.